Human ECRG4 immune microsphere detection kit

By preparing human ECRG4 immunomicrospheres and detecting FITC fluorescence intensity with flow cytometry, the problem of cumbersome and poor linearity of low concentrations is solved, and rapid and high-sensitivity ECRG4 protein detection is achieved, especially at low concentrations Better linearity in range.

CN118937664AInactive Publication Date: 2024-11-12TAIZHOU MUNICIPAL HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411013790.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing ELISA detection method is cumbersome and time-consuming for ECRG4 gene detection, and there are problems of false positive results and poor linearity in low concentrations.

Method used

Human ECRG4 immunomicrospheres were prepared, antibodies were synthesized by genes and coated with microspheres, and FITC fluorescence intensity was detected by flow cytometry to indirectly detect the ECRG4 protein content in the liquid to be tested.

Benefits of technology

Fast and highly sensitive ECRG4 protein detection is achieved, with good stability and better linearity in low concentration. The detection sensitivity is 15.0pg/mL, the linear range is 15-6000pg/mL, and the in-batch repeatability coefficient of variation is 6.1-10.4%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937664A_ABST
    Figure CN118937664A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of immunodetection, and particularly discloses a human ECRG4 immune microsphere and a detection kit containing the microsphere. The invention discloses a rapid and efficient preparation method of the human ECRG4 immune microsphere. The method comprises the following steps: 1) preparing an anti-ECRG4 polyclonal antibody; 2) preparing an ECRG4 protein flow detection microsphere; 21) treating the microsphere; the microspheres prepared by the method have good stability, have very small fluorescence change at 4 DEG C, and can be stabilized for at least 45 days after being stored at 4 DEG C; the invention also discloses a method for detecting the ECRG4 molecular marker protein in human peripheral blood by using the microspheres. Compared with the existing elisa detection kit, the kit disclosed by the invention has better sensitivity and linear range.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of immune detection, and specifically discloses a human ECRG4 immune microsphere and a detection kit containing the microsphere. Background Art

[0002] ECRG4 gene, full name esophageal cancer-related gene 4, is a gene closely related to a variety of biological processes. Recent studies have shown that ECRG4 gene plays an important role in the occurrence, development and metastasis of tumors, especially in digestive system tumors such as esophageal cancer and gastric cancer. Therefore, the study of ECRG4 gene not only helps to deeply understand the occurrence mechanism of tumors, but also provides new ideas for the diagnosis and treatment of tumors.

[0003] The current mainstream ECRG4 gene detection method is the ELISA detection method, which is a detection method based on enzyme-linked immunosorbent assay technology and can be used to detect the content of ECRG4 protein in body fluids such as serum and tissue fluid. This method is simple and fast to operate, has high sensitivity and specificity, and is suitable for screening and detection of large-scale samples. By using a high-quality ECRG4 detection kit, the accurate determination of the ECRG4 protein content can be achieved, providing strong support for the diagnosis and prognosis evaluation of tumors. However, the above-mentioned ELISA detection method has the following disadvantages: the ELISA experiment requires multiple steps, including coating, washing, blocking, adding samples, washing, adding enzyme-labeled reagents, color development, etc. The entire experimental process is relatively cumbersome and requires a lot of time and manpower. At the same time, the ELISA detection method may have false positive results, that is, the experimental results are inconsistent with the actual situation, and need to be combined with other detection methods for verification and confirmation; further, the current ELISA detection method has poor linearity at low concentrations, which limits its ability to obtain more accurate results. Summary of the invention

[0004] Based on the deficiencies in the prior art, the present invention discloses a human ECRG4 immune microsphere detection kit.

[0005] The present invention includes the following technical solutions:

[0006] A human ECRG4 immune microsphere is prepared by the following steps:

[0007] 1) Preparation of anti-ECRG4 polyclonal antibodies

[0008] Gene synthesis of human ECRG4 gene expression sequence, inserted into the eukaryotic expression plasmid pcDNA3.1, to construct the eukaryotic expression plasmid pcDNA3.1-ECRG4, the plasmid was injected intramuscularly to immunize rabbits for several times, each time interval was several weeks, several days after the immunization, blood was collected from the heart, the serum was separated by centrifugation, and passed through an affinity chromatography column to recover the anti-ECRG4 polyclonal antibody;

[0009] 2) Preparation of ECRG4 protein flow cytometry detection microspheres;

[0010] 21) Microsphere treatment: Weigh a number of microspheres and place them in a covered round-bottom centrifuge tube, add an appropriate amount of acetone, mix well, seal, and place on a shaker overnight, centrifuge, wash with distilled water, resuspend in distilled water, and store at room temperature;

[0011] 22) Immunomicrosphere coating: Mix an appropriate amount of ECRG4 polyclonal antibody and coating buffer solution, then add an appropriate amount of mixed microspheres, and place on a shaker at a temperature close to freezing overnight for coating; the next day, centrifuge and wash several times with Tween20 / PBS, block the coated microspheres with appropriate concentration of BSA / PBS, incubate at room temperature on a shaker, centrifuge, wash several times with Tween 20 / PBS, resuspend the microspheres with PBS after washing, and store at a temperature close to freezing for later use.

[0012] Preferably, in the above-mentioned human ECRG4 immune microspheres, in the step 1), the human ECRG4 gene expression sequence is gene synthesized and inserted into the eukaryotic expression plasmid pcDNA3.1 to construct the eukaryotic expression plasmid pcDNA3.1-ECRG4, and 100 μg of the plasmid is injected intramuscularly to immunize rabbits for 3 consecutive immunizations, with an interval of 2 weeks between each immunization, and blood is collected from the heart 10 days after the third immunization.

[0013] Preferably, in the above-mentioned human ECRG4 immune microspheres, in the step 21), 100 mg of microspheres are weighed and placed in a covered round-bottom centrifuge tube, 2 ml of HPLC grade acetone is added, mixed and sealed, and then placed on a shaker overnight, centrifuged at 1000 r / min for 10 minutes, washed 6 times with distilled water, resuspended in 2.5 ml of distilled water, and stored at room temperature.

[0014] Preferably, in the above human ECRG4 immune microspheres, in step 22), 30 μL of ECRG4 polyclonal antibody is mixed with 920 μL of coating buffer solution, and then 50 μL of the mixed solution is added, 3×10 4microspheres; the ratio of antibody to microspheres was 15ug antibody: 1mg microspheres, placed in a shaker at 4°C refrigerator overnight; the next day, centrifuged at 1000r / m for 10min, washed 3 times with 0.05% Tween 20 / PBS; blocked the coated microspheres with 2% BSA / PBS, placed in a shaker at room temperature for 2h; centrifuged at 1000r / m for 10min, washed 3 times with 0.05% Tween20 / PBS; after washing, the microspheres were resuspended with 1ml PBS, the final concentration of the microspheres was 2mg / ml, and stored at 4°C for future use.

[0015] The invention also discloses a human ECRG4 immune microsphere detection kit, which contains the human ECRG4 immune microsphere.

[0016] Preferably, the above-mentioned human ECRG4 immune microsphere detection kit further includes 0.05% Tween20 / PBS washing solution, 0.01% PBS resuspension solution, and FITC-labeled rabbit anti-human polyclonal antibody, wherein the FITC-labeled rabbit anti-human polyclonal antibody is obtained by adding FITC label to ECRG4 polyclonal antibody.

[0017] The present invention also discloses the use of the human ECRG4 immune microsphere detection kit in preparing a medicine for treating esophageal cancer.

[0018] Furthermore, in the above use, the following detection method is included:

[0019] 1) Reaction: Pipette 50 μl of coated detection microspheres and mix well, add 50 μl of the test liquid, and incubate at room temperature with shaking for 2 hours; centrifuge at 1500 r / m for 5 minutes, discard the supernatant, wash 3 times with 0.05% Tween 20 / PBS, and then resuspend with 50 μl 0.01% PBS; add 10 μl of 10 μg / ml FITC-labeled rabbit anti-human polyclonal antibody, incubate at room temperature with shaking for 30 minutes, wash and resuspend with 600 μL PBS;

[0020] 2) Flow cytometer detection: Use CXP2.0 software to detect on the flow cytometer, count 1500-2000 microspheres, and detect the fluorescence intensity of FITC on the microspheres on the flow cytometer to indirectly detect the content of ECRG4 protein in the liquid to be tested.

[0021] Furthermore, in the above-mentioned use, the liquid to be tested is human peripheral blood, and further, it can be serum.

[0022] Compared with the prior art, the present invention has the following outstanding beneficial effects:

[0023] The present invention discloses a human ECRG4 immune microsphere and a detection kit containing the microsphere. The microsphere prepared by the method has good stability, very small fluorescence change at 4°C, and can be stable for at least 45 days when stored at 4°C. The present invention also discloses a detection method for ECRG4 molecular marker protein in human peripheral blood using the microsphere, with a detection sensitivity of 15.0 pg / mL, a linear range of 15-6000 pg / mL, and an intra-batch repeatability coefficient of variation of 6.1-10.4%. The kit can be used to quickly and conveniently detect human ECRG4 molecular marker protein, and has greater advantages than the existing ELISA detection kit with a common sensitivity of 30.0 pg / mL and a linear range of 80-5000 pg / mL, especially better linearity in a low concentration range. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 ; Detection principle of the immune microspheres prepared by the present invention. DETAILED DESCRIPTION

[0025] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0026] Example 1

[0027] A human ECRG4 immune microsphere is prepared by the following steps:

[0028] In step 1), the human ECRG4 gene expression sequence is synthesized and inserted into the eukaryotic expression plasmid pcDNA3.1 to construct the eukaryotic expression plasmid pcDNA3.1-ECRG4. The plasmid 100 μg is injected intramuscularly to immunize rabbits for 3 consecutive immunizations, with an interval of 2 weeks between each immunization. Blood is collected from the heart 10 days after the third immunization.

[0029] Step 2) preparing ECRG4 protein flow cytometry detection microspheres;

[0030] Step 21) Microsphere treatment: Weigh 100 mg of microspheres into a covered round-bottom centrifuge tube, add 2 ml of HPLC-grade acetone, mix well, seal, and place on a shaker overnight, centrifuge at 1000 r / min for 10 minutes, wash 6 times with distilled water, resuspend in 2.5 ml of distilled water, and store at room temperature.

[0031] Step 22) Immunomicrosphere coating: 30 μL ECRG4 polyclonal antibody was mixed with 920 μL coating buffer solution, and then 50 μL of the mixed solution was added, 3×10 4microspheres; the ratio of antibody to microspheres was 15ug antibody: 1mg microspheres, placed in a shaker at 4°C refrigerator overnight; the next day, centrifuged at 1000r / m for 10min, washed 3 times with 0.05% Tween 20 / PBS; blocked the coated microspheres with 2% BSA / PBS, placed in a shaker at room temperature for 2h; centrifuged at 1000r / m for 10min, washed 3 times with 0.05% Tween 20 / PBS; after washing, the microspheres were resuspended with 1ml PBS, the final concentration of the microspheres was 2mg / ml, and stored at 4°C for later use.

[0032] Example 2

[0033] A human ECRG4 immune microsphere detection kit, comprising the human ECRG4 immune microspheres prepared in Example 1, and also comprising 0.05% Tween 20 / PBS washing solution, 0.01% PBS resuspension solution, and FITC-labeled rabbit anti-human polyclonal antibody, wherein the FITC-labeled rabbit anti-human polyclonal antibody is obtained by adding FITC label to ECRG4 polyclonal antibody; the detection principle of the kit is as follows Figure 1 shown.

[0034] Example 3

[0035] The detection method of the human ECRG4 immune microsphere detection kit prepared in Example 2 comprises the following steps:

[0036] 1) Reaction: Pipette 50 μl of coated detection microspheres and mix well, add 50 μl of the test liquid (peripheral blood serum), shake and incubate at room temperature for 2 hours; centrifuge at 1500r / m for 5 minutes, discard the supernatant, wash 3 times with 0.05% Tween 20 / PBS, and then resuspend with 50 μl 0.01% PBS; add 10 μl of 10 μg / ml FITC-labeled rabbit anti-human polyclonal antibody, shake and incubate at room temperature for 30 minutes, wash and resuspend with 600 μL PBS;

[0037] 2) Flow cytometer detection: Use CXP2.0 software to detect on the flow cytometer, count 1500-2000 microspheres, and detect the fluorescence intensity of FITC on the microspheres on the flow cytometer to indirectly detect the content of ECRG4 protein in the liquid to be tested.

[0038] After testing, it was found that the detection sensitivity of this method is 15.0pg / mL, the linear range is 15-6000pg / mL, and the intra-batch repeatability coefficient of variation is 6.1-10.4%; this kit can be used to quickly and conveniently detect human ECRG4 molecular marker protein. Compared with the existing ELISA detection kits with a usual sensitivity of 30.0pg / mL and a linear range of 80-5000pg / mL, it has greater advantages, especially the linearity in the low concentration range is better.

[0039] The above are only a few preferred embodiments of the present invention, which are described in a more specific and detailed manner, but they cannot be understood as limiting the scope of the present invention. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.

Claims

1. A human ECRG4 immune microsphere, characterized in that: Prepared by the following steps: 1) Preparation of anti-ECRG4 polyclonal antibodies Gene synthesis of human ECRG4 gene expression sequence, inserted into the eukaryotic expression plasmid pcDNA3.1, to construct the eukaryotic expression plasmid pcDNA3.1-ECRG4, the plasmid was injected intramuscularly to immunize rabbits for several times, each time interval was several weeks, several days after the immunization, blood was collected from the heart, the serum was separated by centrifugation, and passed through an affinity chromatography column to recover the anti-ECRG4 polyclonal antibody; 2) Preparation of ECRG4 protein flow cytometry detection microspheres; 21) Microsphere treatment: Weigh a number of microspheres and place them in a covered round-bottom centrifuge tube, add an appropriate amount of acetone, mix well, seal, and place on a shaker overnight, centrifuge, wash with distilled water, resuspend in distilled water, and store at room temperature; 22) Immunomicrosphere coating: Mix an appropriate amount of ECRG4 polyclonal antibody and coating buffer solution, then add an appropriate amount of mixed microspheres, and place on a shaker at a temperature close to freezing overnight for coating; the next day, centrifuge and wash several times with Tween20 / PBS, block the coated microspheres with appropriate concentration of BSA / PBS, incubate at room temperature on a shaker, centrifuge, wash several times with Tween 20 / PBS, resuspend the microspheres with PBS after washing, and store at a temperature close to freezing for later use.

2. The human ECRG4 immune microsphere according to claim 1, characterized in that: In the step 1), human ECRG4 gene expression sequence is gene synthesized and inserted into eukaryotic expression plasmid pcDNA3.1 to construct eukaryotic expression plasmid pcDNA3.1-ECRG4. 100 μg of the plasmid is injected intramuscularly to immunize rabbits for 3 consecutive immunizations, with an interval of 2 weeks between each immunization. Blood is collected from the heart 10 days after the third immunization.

3. The human ECRG4 immune microsphere according to claim 1, characterized in that: In the step 21), 100 mg of microspheres were weighed and placed in a covered round-bottom centrifuge tube, 2 ml of HPLC-grade acetone was added, the tube was mixed and sealed, and then placed on a shaker overnight, centrifuged at 1000 r / min for 10 minutes, washed 6 times with distilled water, resuspended in 2.5 ml of distilled water, and stored at room temperature.

4. The human ECRG4 immune microsphere according to claim 1, characterized in that: In step 22), 30 μL ERG4 polyclonal antibody was mixed with 920 μL coating buffer solution, and then 50 μL of the mixed solution was added, and 3×10 4 Microspheres; the ratio of antibody to microspheres was 15ug antibody: 1mg microspheres, placed in a shaker at 4°C refrigerator overnight; the next day, centrifuged at 1000r / m for 10min, and washed 3 times with 0.05% Tween 20 / PBS; The coated microspheres were blocked with 2% BSA / PBS and incubated on a shaker at room temperature for 2 h; centrifuged at 1000 rpm for 10 min, and washed three times with 0.05% Tween 20 / PBS; After washing, the microspheres were resuspended in 1 ml of PBS, the final concentration of the microspheres was 2 mg / ml, and stored at 4°C for later use.

5. A human ECRG4 immune microsphere detection kit, characterized in that: Containing the human ECRG4 immune microspheres as described in any one of claims 1-4.

6. A human ECRG4 immune microsphere detection kit according to claim 5, characterized in that: The method also includes 0.05% Tween 20 / PBS washing solution, 0.01% PBS resuspension solution, and FITC-labeled rabbit anti-human polyclonal antibody. The FITC-labeled rabbit anti-human polyclonal antibody is obtained by adding FITC label to ECRG4 polyclonal antibody.

7. Use of the human ECRG4 immune microsphere detection kit as claimed in claim 7 in the preparation of a drug for treating esophageal cancer.

8. The use according to claim 7, characterized in that The following detection methods are included: 1) Reaction: Pipette 50 μl of coated detection microspheres and mix well, add 50 μl of the test liquid, and incubate at room temperature with shaking for 2 hours; centrifuge at 1500 r / m for 5 minutes, discard the supernatant, wash 3 times with 0.05% Tween 20 / PBS, and then resuspend with 50 μl 0.01% PBS; add 10 μl of 10 μg / ml FITC-labeled rabbit anti-human polyclonal antibody, incubate at room temperature with shaking for 30 minutes, wash and resuspend with 600 μL PBS; 2) Flow cytometer detection: Use CXP2.0 software to detect on the flow cytometer, count 1500-2000 microspheres, and detect the fluorescence intensity of FITC on the microspheres on the flow cytometer to indirectly detect the content of ECRG4 protein in the liquid to be tested.

9. The use according to claim 8, characterized in that The liquid to be tested is human peripheral blood.